ALAM JOHN J Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
31
Insider Sells Sum
$4.69M

Insider Activity of ALAM JOHN J

According to the SEC Form 4 filings, ALAM JOHN J, being in a position of

  1. CEO & President at CervoMed Inc.,
    оver the last 12 months, has bought 35000 shares for $282,652, and sold 0 shares,
    over all time since 2025-11-12, has bought 35000 shares for $282,652, and sold 0 shares.

Biography of ALAM JOHN J

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $282,6524100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2025-11-17PurchaseCervoMed Inc.
CRVO
CEO & President
21,600
0.2406%
$8.46$182,736-54.69%
2025-11-14PurchaseCervoMed Inc.
CRVO
CEO & President
3,400
0.0383%
$7.56$25,704-51.56%
2025-11-13PurchaseCervoMed Inc.
CRVO
CEO & President
4,447
0.0498%
$7.51$33,397-48.69%
2025-11-12PurchaseCervoMed Inc.
CRVO
CEO & President
5,553
0.0637%
$7.35$40,815-49.73%
2008-10-01SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Med. Dev. Group & CMO
4,253
0.0027%
$32.65$138,860-6.88%
2008-09-10SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Med. Dev. Group & CMO
6,614
0.0046%
$26.23$173,485+11.49%
2008-09-03SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Med. Dev. Group & CMO
6,612
0.0046%
$25.86$170,986+13.11%
2008-08-27SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Med. Dev. Group & CMO
6,612
0.0047%
$27.02$178,656+9.1%
2008-08-20SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Med. Dev. Group & CMO
6,612
0.0049%
$27.57$182,302+11.42%
2008-05-21SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Med. Dev. Group & CMO
80
<0.0001%
$27.89$2,231+11.18%
2008-05-20SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Med. Dev. Group & CMO
722
0.0005%
$27.59$19,918+5.48%
2007-12-11SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Medicines Dev. & CMO
480
0.0004%
$25.62$12,298+4.25%
2007-11-16SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Medicines Dev. & CMO
1
<0.0001%
$25.82$26+1.94%
2007-08-06SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Medicines Dev. & CMO
30,720
0.0231%
$35.00$1.08M-25.92%
2007-05-17SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Medicines Dev. & CMO
794
0.0006%
$31.95$25,368-15.96%
2007-05-07SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Medicines Dev. & CMO
32,500
0.0253%
$30.59$994,175-13.25%
2007-01-31SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Medicines Dev., & CMO
1,500
0.0012%
$35.46$53,190-14.85%
2007-01-24SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Med. Product Dev. & CMO
1,500
0.0012%
$36.20$54,300-16.16%
2007-01-17SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Medicines Dev., & CMO
1,500
0.0012%
$38.29$57,435-19.42%
2007-01-10SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Medicines Dev., & CMO
1,500
0.0012%
$35.00$52,500-13.18%
Total: 35
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.